These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8538647)

  • 41. p21CDKN1A Regulates the Binding of Poly(ADP-Ribose) Polymerase-1 to DNA Repair Intermediates.
    Dutto I; Sukhanova M; Tillhon M; Cazzalini O; Stivala LA; Scovassi AI; Lavrik O; Prosperi E
    PLoS One; 2016; 11(1):e0146031. PubMed ID: 26730949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protection of CHO cells by mutant forms of O6-alkylguanine-DNA alkyltransferase from killing by 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) plus O6-benzylguanine or O6-benzyl-8-oxoguanine.
    Loktionova NA; Xu-Welliver M; Crone TM; Kanugula S; Pegg AE
    Biochem Pharmacol; 1999 Jul; 58(2):237-44. PubMed ID: 10423163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
    Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G
    Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blockage of abasic site repair enhances antitumor efficacy of 1,3-bis-(2-chloroethyl)-1-nitrosourea in colon tumor xenografts.
    Liu L; Yan L; Donze JR; Gerson SL
    Mol Cancer Ther; 2003 Oct; 2(10):1061-6. PubMed ID: 14578471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Formation and repair of 1,3-bis-(2-chloroethyl)-1-nitrosourea and cisplatin induced total genomic DNA interstrand crosslinks in human glioma cells.
    Ali-Osman F; Rairkar A; Young P
    Cancer Biochem Biophys; 1995 Jan; 14(4):231-41. PubMed ID: 7767897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy.
    Nutt CL; Noble M; Chambers AF; Cairncross JG
    Cancer Res; 2000 Sep; 60(17):4812-8. PubMed ID: 10987291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.
    Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS
    J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of resistance to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) in sensitive and resistant human glioma cells.
    Skalski V; Yarosh DB; Batist G; Gros P; Feindel W; Kopriva D; Panasci LC
    Mol Pharmacol; 1990 Sep; 38(3):299-305. PubMed ID: 2402223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNA repair, ADP-ribosylation and pyridine nucleotide metabolism as targets for cancer chemotherapy.
    Berger NA; Berger SJ; Gerson SL
    Anticancer Drug Des; 1987 Oct; 2(2):203-9. PubMed ID: 3329525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tetrazepinones are equally cytotoxic to Mer+ and Mer- human tumor cell lines.
    Jean-Claude BJ; Mustafa A; Watson AJ; Damian Z; Vasilescu D; Chan TH; Leyland-Jones B
    J Pharmacol Exp Ther; 1999 Feb; 288(2):484-9. PubMed ID: 9918549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of a specific DNA repair system and nitrosourea cytotoxicity in resistant human cancer cells.
    Futscher BW; Micetich KC; Barnes DM; Fisher RI; Erickson LC
    Cancer Commun; 1989; 1(1):65-73. PubMed ID: 2534817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro pharmacokinetics and pharmacodynamics of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).
    Ueda-Kawamitsu H; Lawson TA; Gwilt PR
    Biochem Pharmacol; 2002 Apr; 63(7):1209-18. PubMed ID: 11960597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cells.
    Senhaji Mouhri Z; Goodfellow E; Jean-Claude B
    BMC Cancer; 2017 Aug; 17(1):540. PubMed ID: 28800752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glutathione content and glutathione-S-transferase expression in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human malignant astrocytoma cell lines.
    Ali-Osman F; Stein DE; Renwick A
    Cancer Res; 1990 Nov; 50(21):6976-80. PubMed ID: 2208164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1.
    Plummer ER; Middleton MR; Jones C; Olsen A; Hickson I; McHugh P; Margison GP; McGown G; Thorncroft M; Watson AJ; Boddy AV; Calvert AH; Harris AL; Newell DR; Curtin NJ
    Clin Cancer Res; 2005 May; 11(9):3402-9. PubMed ID: 15867241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Hank NC; Shapiro JR; Scheck AC
    BMC Cancer; 2006 Jan; 6():2. PubMed ID: 16393339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BCNU is a caspase-mediated inhibitor of drug-induced apoptosis.
    Peták I; Mihalik R; Bauer PI; Süli-Vargha H; Sebestyén A; Kopper L
    Cancer Res; 1998 Feb; 58(4):614-8. PubMed ID: 9485009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcriptional repression of O6-methylguanine DNA methyltransferase gene rendering cells hypersensitive to N,N'-bis(2-chloroethyl)-N-nitrosurea in camptothecin-resistant cells.
    Ma LC; Kuo CC; Liu JF; Chen LT; Chang JY
    Mol Pharmacol; 2008 Aug; 74(2):517-26. PubMed ID: 18492797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Kurpad SN; Dolan ME; McLendon RE; Archer GE; Moschel RC; Pegg AE; Bigner DD; Friedman HS
    Cancer Chemother Pharmacol; 1997; 39(4):307-16. PubMed ID: 9025771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of transforming growth factor-beta1-binding protein overexpression in carmustine-resistant glioma cells by MRNA differential display.
    Norman SA; Rhodes SN; Treasurywala S; Hoelzinger DB; Rankin Shapiro J; Scheck AC
    Cancer; 2000 Aug; 89(4):850-62. PubMed ID: 10951349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.